1.Expert consensus on thrombolytic therapy for ST-segment elevation myocardial infarction
Cardiology Branch of Jiangsu Medical Association ; Cardiology Branch of Jiangsu Medical Doctor Association ; Cardiac Critical Care Specialized Committee of Jiangsu Medical Doctor Association ; Basic & Medication Panel Affiliated to Cardiology Branch of Jiangsu Medical Association ; Chun-Jian LI ; Gen-Shan MA ; Biao XU ; Xiang-Qing KONG
Chinese Journal of Interventional Cardiology 2024;32(7):364-382
Thrombolytic therapy plays a vital role in reperfusion strategy for ST-segment elevation myocardial infarction(STEMI)patients.Previous Chinese expert consensus focused on pre-hospital thrombolysis therapy in STEMI patients was published in 2018 which tremendously promoted pre-hospital thrombolysis therapy.In recent years,plenty of research progress and results of clinical trials have been released in following areas such as STEMI reperfusion strategy,anti-platelet/anti-coagulants therapy,contemporary facilitated percutaneous coronary intervention,and so on.Meanwhile,the COVID-19 pandemic makes timely reperfusion for STEMI patients even more challenging.Therefore,this consensus has been proposed aiming to summarize recent progress in STEMI thrombolysis therapy and to provide practical & evidence-based instructions conforming to national conditions.We hope this consensus will contribute to the emergency management and long-term prognosis of STEMI patients.